Release Date: 10/12/18 09:14 Summary: Ongoing Disclosure Notice - Sarah Thompson (amended) Price Sensitive: No Download Document 857.15KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status